Kiniksa Pharmaceuticals International, plc (KNSA) Net margin 2021–2025
Kiniksa Pharmaceuticals International, plc (KNSA) net profit margin by fiscal year — reported net income divided by reported revenue.
8.7%FY2025 · since FY2021: -409.7% → 8.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 8.7% | +18.9 pp |
| FY2024 | -10.2% | -15.4 pp |
| FY2023 | 5.2% | -78.1 pp |
| FY2022 | 83.3% | +493.0 pp |
| FY2021 | -409.7% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice